Skip to main content
. Author manuscript; available in PMC: 2008 Sep 9.
Published in final edited form as: Am J Transplant. 2008 Apr 29;8(6):1297–1302. doi: 10.1111/j.1600-6143.2008.02220.x

Table 1.

Patient demographics

IV GCV vs. VGCV 900 PO GCV vs. VGCV 450 mg
Age 39 (29–54) 39 (28–64)
Gender (male/female)
 Male 4 4
 Female 3 3
Estimated GFR (mL/min) Phase I: 66 (61–107) Phase III: 64 (61–73)
Phase II: 62 (60–68) Phase IV: 66 (56–102)
Race
 White 3 3
 Black 4 4
CMV status
 D−/R− 2 2
 D+/R− 2 2
D+/R+ 1 1
 D−/R+ 2 2
Induction therapy
 Rabbit ATG 5 5
 Alemtuzumab 2 2
Immunosuppresion
 Sirolimus/tacrolimus 5 5
 Tacrolimus 2 2

Median with ranges in parentheses.

GFR = glomerular filtration rate.